Description:AZD-4205 is a chemical compound that has garnered attention in pharmaceutical research, particularly for its potential therapeutic applications. It is classified as a selective antagonist of the orexin receptor, which plays a crucial role in regulating sleep-wake cycles and appetite. The compound's mechanism of action involves blocking the orexin receptors, thereby influencing neurobiological pathways associated with sleep disorders and possibly obesity. AZD-4205 is characterized by its specific binding affinity to the orexin receptors, which distinguishes it from other compounds in the same class. Its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion, are essential for determining its efficacy and safety profile in clinical settings. Ongoing studies aim to evaluate its therapeutic potential, side effects, and overall impact on conditions like insomnia and other sleep-related disorders. As research progresses, AZD-4205 may contribute to the development of new treatments that target orexin signaling pathways.
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.
![(R)-N-(3-{2-[(3-Methoxy-1-methyl-1H-pyrazol-4-yl)amino]pyrimidin-4-yl}-1H-indol-7-yl)-2-(4-methylp…](https://static.cymitquimica.com/products/IN/thumb/DA01FNPZ.jpg)
